References
- Alam, M., Mayerhofer, A., & Schmidt, W. (2004). The neurobehavioral changes induced by bilateral rotenone lesion in medial forebrain bundle of rats are reversed by L-DOPA. Behavioural Brain Research, 151(1–2), 117–124. doi:https://doi.org/10.1016/j.bbr.2003.08.014
- Alder, S., & Zbinden, G. (1983). Neurobehavioral tests in single-and repeated-dose toxicity studies in small rodents. Archives of Toxicology, 54, 1–23. doi:https://doi.org/10.1007/BF00277811
- Ali, A., Hamed, M., & El-Sayed, M. (1992). Effect of protein malnutrition on postnatal neurobehavioural response to drugs. M Sc. Thesis, Pharmacology, Faculty of Pharmacy, Cairo University. pp 59-160.
- Ballance, W. C., Qin, E. C., Chung, H. J., Gillette, M. U., & Kong, H. (2019). Reactive oxygen species-responsive drug delivery systems for the treatment of neurodegenerative diseases. Biomaterials, 217, 119292. doi:https://doi.org/10.1016/j.biomaterials.2019.119292
- Bancroft, J. D., & Gamble, M. (2008). Theory and practice of histological techniques. 6th Edition, Churchill Livingstone, Elsevier, China.
- Ben-Ari, Y., Gaiarsa, J. L., Tyzio, R., & Khazipov, R. (2007 Oct). GABA: A pioneer transmitter that excites immature neurons and generates primitive oscillations. Physiological Reviews, 87(4), 1215–1284. doi:https://doi.org/10.1152/physrev.00017.2006. PMID: 17928584.
- Bhide, N., Lindenbach, D., Surrena, M. A., Goldenberg, A. A., Bishop, C., Berger, S. P., Paquette, M. A. (2013). The effects of BMY-14802 against L-DOPA- and dopamine agonist-induced dyskinesia in the hemiparkinsonian rat. Psychopharmacology (Berl), 227, 533–544. doi:https://doi.org/10.1007/s00213-013-3001-4
- Botsford, E., George, J., & Buckley, E. E. (2018). Parkinson’s disease and metal storage disorders: A systematic review. Brain Sciences, 8. doi:https://doi.org/10.3390/brainsci8110194
- Costa, C. M., de Oliveira, G. L., Fonseca, A. C. S., Lana, R. D. C., Polese, J. C., Pernambuco, A. P. (2019). Levels of cortisol and neurotrophic factor brain-derived in parkinson’s disease. Neurosci. Lett, 708, 134359. doi:https://doi.org/10.1016/j.neulet.2019.134359
- Cova, I., Leta, V., Mariani, C., Pantoni, L., & Pomati, S. (2019). Exploring cocoa properties: Is theobromine a cognitive modulator?. Psychopharmacology (Berl), 236(2), 561–572. doi:https://doi.org/10.1007/s00213-019-5172-0
- Cunha, J. M., & Masur, J. (1978). Evaluation of psychotropic drugs with a modified open field test. Pharmacol, 16, 259–267. doi:https://doi.org/10.1159/000136777
- Ellman, G. L., Courtney, K. D., Andres, V., & Featherstone, R. M. (1961). A new and rapid colorimetric determination of acetylcholinesterase activity. Biochemical Pharmacology, 7(2), 88. IN191–9095. doi:https://doi.org/10.1016/0006-2952(61)90145-9
- Ginsberg, Y., Khatib, N., Saadi, N., Ross, M. G., Weiner, Z., Beloosesky, R. (2018). Maternal pomegranate juice attenuates maternal inflammation-induced fetal brain injury by inhibition of apoptosis, neuronal nitric oxide synthase, and NF-κB in a rat model. Am. J. Obstet. Gynecol, 219, 113.e1–113.e9. doi:https://doi.org/10.1016/j.ajog.2018.04.040
- Hamed, M., & El-Sayed, M. (1991). Influence of protein malnutrition on behavioral response to drugs in rats. JOURNAL OF DRUG RESEARCH-CAIRO, 20, 241.
- Hamed, M. R., Khayyal, M. T. E., Mansour, H. A. F., & Al-Ansary, D. M. (2006). Immunomodulatory effects of dimethyl- 4, 4- Dimethoxy-5,5,5,6- Dimethylene Dioxy-Biphenyl- Dicarboxylate (D.D.B). J Drug Res Egypt, 27(1–2), 32–43.
- Hassanzadeh, K., Rahimmi, A., & Hassanzadeh, K. (2014). Effect of N-acetylcysteine on TNF-α level of substantia nigra and striatum in rat model of parkinson’s disease. J. Mazandaran Univ. Med. Sci, 24(118), 40–48.
- Hirsch, E. C., & Hunot, S. (2009). Neuroinflammation in parkinson’s disease: A target for neuroprotection?. Lancet Neurology, 8(4), 382–397. doi:https://doi.org/10.1016/S1474-4422(09)70062-6
- Hirsch, E. C., Hunot, S., & Hartmann, A. (2005). Neuroinflammatory processes in parkinson’s disease. Parkinson. Relat. Disord, 11(Suppl. 1), S9–S15. doi:https://doi.org/10.1016/j.parkreldis.2004.10.013
- Ishola, I. O., Akinyede, A. A., Adeluwa, T. P., & Micah, C. (2018). Novel action of vinpocetine in the prevention of paraquat-induced parkinsonism in mice: Involvement of oxidative stress and neuroinflammation. Metab. Brain Dis, 33, 1493–1500. doi:https://doi.org/10.1007/s11011-018-0256-9
- Kaur, G., Jabbar, Z., Athar, M., & Alam, M. S. (2006). Punica granatum (pomegranate) flower extract possesses potent antioxidant activity and abrogates Fe-NTA induced hepatotoxicity in mice. Food Chem. Toxicol, 44, 984–993. doi:https://doi.org/10.1016/j.fct.2005.12.001
- Kelly, M. J., Lawton, M. A., Baig, F., Ruffmann, C., Barber, T. R., Lo, C., Klein, J. C., Ben- Shlomo, Y., Hu, M. T. (2019). Predictors of motor complications in early parkinson’s disease: A prospective cohort study. Mov. Disord. doi:https://doi.org/10.1002/mds.27783.
- Kilari, E. K., Rao, L. S. N., Sreemanthula, S., & Kola, P. K. (2015). Anti-stress and nootropic activity of aqueous extract of piper longum fruit, estimated by noninvasive biomarkers and Y-maze test in rodents. Environ Exp Biol, 13, 25–31.
- Kovalchuk, Y., Hanse, E., Kafitz, K. W., & Konnerth, A. (2002). Postsynaptic induction of BDNF-mediated long-term potentiation. Science. 295, 1729–1734.
- Kujawska, M., Jourdes, M., & Kurpik, M. (2019). Neuroprotective effects of pomegranate juice against parkinson’s disease and presence of ellagitannins-derived metabolite-Urolithin A-in the brain. International Journal of Molecular Sciences, 21(1), Published 2019 Dec 27, 202. doi:https://doi.org/10.3390/ijms21010202
- Liu-T, H., Luo-C, L., Huang, B., & Lu-T, S. (2018). FuY-S 2018: the caffeine effects on rotenone-induced parkinson’s disease model in vitro and in vivo. Experimental Biology, 32(S1), 740.2.
- Livak, K. J., & Schmittgen, T. D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods, 25, 402–408. doi:https://doi.org/10.1006/meth.2001.1262
- Malek, N., Kanavou, S., Lawton, M. A., Pitz, V., Grosset, K. A., Bajaj, N.,Barker, R. A., Ben Shlomo, Y., Burn, D. J., Foltynie, T., Hardy, J., Williams, N. M., Wood, N., Morris, H. R., Grosset, D. G. (2019). L-dopa responsiveness in early parkinson’s disease is associated with the rate of motor progression. Parkinsonism Relat. Disord. doi:https://doi.org/10.1016/j.parkreldis.2019.05.022.
- Mazumder, M. K., Choudhury, S., & Borah, A. (2019). An in silico investigation on the inhibitory potential of the constituents of pomegranate juice on antioxidant defense mechanism: relevance to neurodegenerative diseases. IBRO Reports, 6, 153–159. doi:https://doi.org/10.1016/j.ibror.2019.05.003
- Medina, A. E. (2010). Vinpocetine as a potent antiinflammatory agent. PNAS, 107(22), 9921–9922. doi:https://doi.org/10.1073/pnas.1005138107
- Messaoudi, M., Bisson, J.F., Nejdi, A., Rozan, P., & Javelot, H. (2008). Antidepressant-like effects of a cocoa polyphenolic extract in wistar-unilever rats. Nutr. Neurosci, 11, 269–276. doi:https://doi.org/10.1179/147683008X344165
- Nadeem, R. I., Ahmed, H. I., & El-Sayeh, B. M. (2018). Protective effect of vinpocetine against neurotoxicity of manganese in adult male rats. Naunyn. Schmiedebergs. Arch. Pharmacol, 3(91), 729–742. doi:https://doi.org/10.1007/s00210-018-1498-0
- Petit-Paitel, A. (2010). [GSK-3beta: A central kinase for neurodegenerative diseases?]. Med. Sci. (Paris), 26, 516–521. doi:https://doi.org/10.1051/medsci/2010265516
- Pfaffl, M. W. (2001). A new mathematical model for relative quantification in real-time RT–PCR. Nucleic Acids Research. 29, e45–e45.
- Rekha, K. R., & Inmozhi Sivakamasundari, R. (2018). Geraniol protects against the Protein and Oxidative stress induced by rotenone in an in vitro model of parkinson’s disease. Neurochem. Res, 43, 1947–1962. doi:https://doi.org/10.1007/s11064-018-2617-5
- Safari, M., Sameni, H. R., Badban, L., Bandegi, A. R., Vafaei, A. A., Pour, A. R., Ghahari, L.,l (2015). Protective effects of water extract of propolis on dopaminergic neurons, brain derived neurotrophic factor and stress oxidative factors in the rat model of parkinson’s disease. International Journal of Pharmacology, 11(4), 300–308. doi:https://doi.org/10.3923/ijp.2015.300.308
- Sanberg, P. R. (1988). The catalepsy test: Its ups and downs. Behavioral Neuroscience, 102(5), 748. doi:https://doi.org/10.1037/0735-7044.102.5.748
- Sarter, M., Schneider, H. H., & Stephens, D. N. (1988). Treatment strategies for senile dementia: Antagonist β-carbolines. Trends in Neurosciences, 11, 13–17. doi:https://doi.org/10.1016/0166-2236(88)90042-2
- Silva, J., Alves, C., Freitas, R., Martins, A., Pinteus, S., Ribeiro, J., Gaspar, H., Alfonso, A., Pedrosa, R. (2019). Antioxidant and neuroprotective potential of the brown seaweed bifurcaria bifurcata in an in vitro parkinson’s disease model. Mar. Drugs, 17. doi:https://doi.org/10.3390/md17020085
- Sokolova, A. N., Pavlova, M. A., Klosterhalfena, S., & Enck, P. (2013). Chocolate and the brain: neurobiological impact of cocoa flavanols on cognition and behaviour. Neuroscience and Biobehavioral Reviews, 37(10), 2445–2453. doi:https://doi.org/10.1016/j.neubiorev.2013.06.013
- Tapias, V., Cannon, J. R., & Greenamyre, J. T. (2014). Pomegranate juice exacerbates oxidative stress and nigrostriatal degeneration in Parkinson’s disease. Neurobiology of Aging, 35, 1162–1176. doi:https://doi.org/10.1016/j.neurobiolaging.2013.10.077
- Teixeira, M. D., Souza, C. M., Menezes, A. P., Carmo, M. R., & Fonteles, A. A. (2013). Catechin attenuates behavioral neurotoxicity induced by 6-OHDA in rats. Pharmacology, Biochemistry, and Behavior, 110, 1–7. doi:https://doi.org/10.1016/j.pbb.2013.05.012
- Usman, U. Z., Bakar, A. B. A., & Mohamed, M. (2018). Propolis improves pregnancy outcomes and placental oxidative stress status in streptozotocin-induced diabetic rats. BMC Complement. Altern. Med, 18, 324. doi:https://doi.org/10.1186/s12906-018-2391-6
- Van den Buuse, M., & De jong, W. (1989). Differential effects of dopaminergic drugs on open- field behavior of spontaneously hypertensive rats and normotensive wistar –kyoto rats. The Journal of Pharmacology and Experimental Therapeutics, 248(3), 1189–1196.
- Vorhees, C. V. (1974). Some behavioral effects of maternal hypervitaminosis A in rats. Teratology, 10, 269–273. doi:https://doi.org/10.1002/tera.1420100309
- Vorhees, C. V., Klein, K. L., & Scott, W. J. (1982). Aspirin‐induced psychoteratogenesis in rats as a function of embryonic age. Teratogenesis, Carcinogenesis, and Mutagenesis. 2, 77–84. doi:https://doi.org/10.1002/1520-6866(1990)2:1<77:AID-TCM1770020108>3.0.CO;2-C
- Wichmann, T. (2019). Changing views of the pathophysiology of parkinsonism. Mov. Disord. doi:https://doi.org/10.1002/mds.27741
- Yu, A. J., & Dayan, P. (2005). Uncertainty, neuromodulation, and attention. Neuron, 46(4), 681–692. doi:https://doi.org/10.1016/j.neuron.2005.04.026
- Zaitone, S. A., Ahmed, E., Elsherbiny, N. M., Mehanna, E. T., El-Kherbetawy, M. K., ElSayed, M. H., Alshareef, D, M., Moustafa, Y. M. (2019). Caffeic acid improves locomotor activity and lessens inflammatory burden in a mouse model of rotenone-induced nigral neurodegeneration: relevance to parkinson’s disease therapy. Pharmacol. Rep, 71, 32–41. doi:https://doi.org/10.1016/j.pharep.2018.08.004